United Services Automobile Association Buys New Shares in HCA Healthcare, Inc. $HCA

Key Points

• United Services Automobile Association has acquired new shares in HCA Healthcare, amassing 4,387 shares valued at approximately $1.5 million.
• HCA Healthcare reported a quarterly EPS of $6.84, exceeding analysts' expectations, and its revenue increased by 6.4% year-over-year.
• The company announced a quarterly dividend of $0.72 per share, with the ex-dividend date set for September 16th, representing an annualized yield of 0.7%.

United Services Automobile Association acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 4,387 shares of the company's stock, valued at approximately $1,501,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCA. Brighton Jones LLC bought a new position in shares of HCA Healthcare during the fourth quarter valued at about $1,021,000. Cary Street Partners Financial LLC bought a new stake in shares of HCA Healthcare in the fourth quarter worth about $187,000. Cetera Investment Advisers grew its stake in shares of HCA Healthcare by 21.6% in the fourth quarter. Cetera Investment Advisers now owns 29,171 shares of the company's stock worth $8,756,000 after purchasing an additional 5,187 shares during the last quarter. Humankind Investments LLC grew its stake in shares of HCA Healthcare by 15.3% in the fourth quarter. Humankind Investments LLC now owns 4,317 shares of the company's stock worth $1,296,000 after purchasing an additional 573 shares during the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in HCA Healthcare by 14.9% in the fourth quarter. Janus Henderson Group PLC now owns 1,538,826 shares of the company's stock worth $461,883,000 after buying an additional 199,188 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

Shares of HCA opened at $420.68 on Monday. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $420.98. The company has a market capitalization of $98.43 billion, a P/E ratio of 17.68, a price-to-earnings-growth ratio of 1.32 and a beta of 1.41. The firm has a 50 day moving average of $380.14 and a 200 day moving average of $360.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the previous year, the firm posted $5.50 EPS. The firm's revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's payout ratio is presently 12.11%.

Analysts Set New Price Targets

Several brokerages have commented on HCA. Bank of America lowered shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a report on Wednesday, July 16th. Wells Fargo & Company lowered their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a report on Thursday, August 14th. Truist Financial raised their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Cantor Fitzgerald reiterated an "overweight" rating and set a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, August 26th. Finally, Morgan Stanley lowered their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $401.83.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.